No.

Publication Date

Citing Article

1

2024

Lingfang Feng, Tao Li, Biao Xu, Jing Huang, Hailing Xia, Zhaoqiang Jiang, Junfei Chen, Simiao Pan, Xing Zhang, Hua Jiang, Jianlin Lou. Integrated DNA methylation analysis of peripheral blood from asbestos exposed populations and patients with malignant mesothelioma reveals novel methylation driver genes of diagnostic and prognostic relevance, Environmental Pollution. 2024; 362: 124928124928.  https://doi.org/10.1016/j.envpol.2024.124928

2

2025

Yun-Chieh Kao, Chueh-Chuan Yen. Next-generation Sequencing Unlocks New Options in Refractory Sarcomatoid Mesothelioma: A Case Report, Journal of Cancer Research and Practice. 2025; 12: 135.  https://doi.org/10.4103/ejcrp.eJCRP-D-25-00034

3

2024

Elisa Roca, Avinash Aujayeb, Philippe Astoul. Diagnosis of Pleural Mesothelioma: Is Everything Solved at the Present Time?, Current Oncology. 2024; 31: 4968.  https://doi.org/10.3390/curroncol31090368

4

2021

Carminia Maria Della Corte, Flora Cimmino, Floriana Morgillo. Analysis of DNA from liquid biopsy: new genetic biomarkers for cancer immunotherapy?, Exploration of Targeted Anti-tumor Therapy. 2021;   https://doi.org/10.37349/etat.2021.00041

5

2024

Aliakbar Ebrahimi, Güntülü Ak, Ceren Özel, Hüseyin İzgördü, Hamed Ghorbanpoor, Shabir Hassan, Huseyin Avci, Muzaffer Metintaş. Clinical Perspectives and Novel Preclinical Models of Malignant Pleural Mesothelioma: A Critical Review, ACS Pharmacology & Translational Science. 2024; 7: 3299.  https://doi.org/10.1021/acsptsci.4c00324

6

2023

Ding Wang, Jing Zhu, Na Li, Hongyang Lu, Yun Gao, Lei Zhuang, Zhongjian Chen, Weimin Mao. GC-MS-based untargeted metabolic profiling of malignant mesothelioma plasma, PeerJ. 2023; 11: e15302e15302.  https://doi.org/10.7717/peerj.15302

7

2024

Akash Moirangthem, Olive Simick Lepcha, Ranjit Panigrahi, Biswajit Brahma, Akash Kumar Bhoi. Early Malignant Mesothelioma Detection Using Ensemble of Naive Bayes Under Decorate Ensemble Framework, Journal of The Institution of Engineers (India): Series B. 2024; 105: 251.  https://doi.org/10.1007/s40031-023-00988-8

8

2023

Filiz Bogar, Guntulu Ak, Selma Metintas, Adnan Ayhanci, Muzaffer Metintas. Longitudinal monitoring of response to chemotherapy in patients with malignant pleural mesothelioma by biomarkers, Cancer Biomarkers. 2023; 38: 111.  https://doi.org/10.3233/CBM-220436

9

2026

Raffaella Pagliaro, Beatrice Leonardi, Angela Schiattarella, Grazia Bergameo, Carmine Picone, Adolfo Gallipoli D'Errico, Filippo Scialò, Fabio Perrotta, Maria Luisa De Rimini, Alfonso Fiorelli, Andrea Bianco. Emerging Strategies in the Diagnosis and Treatment of Pleural Mesothelioma: An Overview, Thoracic Cancer. 2026; 17: e70259.  https://doi.org/10.1111/1759-7714.70259

10

2023

Licun Wu, Marc de Perrot. Omics Overview of the SPARC Gene in Mesothelioma, Biomolecules. 2023; 13: 1103.  https://doi.org/10.3390/biom13071103

11

2026

Giusi Bondì, Serafina Martella, Dimitrios Stylianakis, Alberto Terminella, Filippo Lococo, Alessia Ciarrocchi, Alfonso Fiorelli, Giacomo Cusumano. Immune Checkpoint Inhibitors in Malignant Pleural Mesothelioma: Efficacy, Real-World Outcomes, and the Search for Predictive Biomarkers, Current Oncology. 2026; 33: 93.  https://doi.org/10.3390/curroncol33020093

12

2026

Berta Mosleh, Yawen Dong, Elisabeth Lang, Thomas Klikovits, Katharina Sinn, Steven Kao, Marko Jakopovic, Clemens Aigner, Balazs Hegedüs, Natalie Baldes, Servet Bölükbas, Balazs Dome, Mir Alireza Hoda, Viktoria Laszlo, Michael Grusch, Karin Schelch. MiR-21 Is a Novel Diagnostic and Prognostic Circulating Biomarker in Pleural Mesothelioma, Diagnostics. 2026; 16: 1142.  https://doi.org/10.3390/diagnostics16081142